Advertisement

Topics

Celltrion Healthcare $890m IPO to up biosimilar inventory and broaden portfolio

08:35 EDT 4 Aug 2017 | BioPharma-Reporter

Original Article: Celltrion Healthcare $890m IPO to up biosimilar inventory and broaden portfolio

NEXT ARTICLE

More From BioPortfolio on "Celltrion Healthcare $890m IPO to up biosimilar inventory and broaden portfolio"

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...